Omaha mother of twins Lauren Koop Daughtrey, right, underwent a newer type of CAR-T cell therapy to target her lupus this spring in a clinical trial at the University of Nebraska Medical Center. Dr. Jennifer Medlin, a rheumatologist with Nebraska Medicine, is the principal investigator of the local trial.
Daughtrey, left, discusses the newer type of CAR-T cell therapy she underwent this spring in a clinical trial at the University of Nebraska Medical Center with Dr. Matthew Lunning. He is medical director of the gene and cellular therapy program at Nebraska Medicine.
Lauren Koop Daughtrey, left, underwent a newer type of CAR-T cell therapy to target her lupus this spring in a clinical trial at the University of Nebraska Medical Center. The Omaha mother can now more easily carry her solidly built 17-month-old twins.
See our best Omaha staff photos & videos from September 2024.
Lauren Koop Daughtrey, left, underwent a newer type of CAR-T cell therapy to target her lupus this spring in a clinical trial at the University of Nebraska Medical Center. The Omaha mother can now more easily carry her solidly built 17-month-old twins.
Omaha mother of twins Lauren Koop Daughtrey, right, underwent a newer type of CAR-T cell therapy to target her lupus this spring in a clinical trial at the University of Nebraska Medical Center. Dr. Jennifer Medlin, a rheumatologist with Nebraska Medicine, is the principal investigator of the local trial.
Daughtrey, left, discusses the newer type of CAR-T cell therapy she underwent this spring in a clinical trial at the University of Nebraska Medical Center with Dr. Matthew Lunning. He is medical director of the gene and cellular therapy program at Nebraska Medicine.
